• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左炔诺孕酮宫内缓释系统治疗子宫内膜息肉和黏膜下子宫肌瘤的宫腔镜处理。

Hysteroscopic management of endometrial polyps and submucous leiomyomas in women using a levonorgestrel-releasing intrauterine system.

机构信息

Department of Obstetrics and Gynaecology, Charles University, First Faculty of Medicine and General Faculty Hospital in Prague, Prague, Czech Republic.

Department of Physiology, Development and Neuroscience, St John's College Teaching Associate, University of Cambridge, Centre for Trophoblast Research, Cambridge, UK.

出版信息

Minim Invasive Ther Allied Technol. 2022 Apr;31(4):615-619. doi: 10.1080/13645706.2020.1870499. Epub 2021 Jan 11.

DOI:10.1080/13645706.2020.1870499
PMID:33428484
Abstract

INTRODUCTION

This study was designed to evaluate the feasibility and effectiveness of hysteroscopy in the management of symptoms related to endometrial polyps and submucous leiomyomas in women using a levonorgestrel-releasing intrauterine system (LNG-IUS).

MATERIAL AND METHODS

Twenty-three LNG-IUS users presenting with endometrial polyps and/or submucous leiomyomas and irregular uterine bleeding were recruited for hysteroscopic examination and surgery. Intrauterine pathology was investigated and treated by hysteroscopic resection with the LNG-IUS , and the effect of the procedure on symptoms was evaluated after three to six months.

RESULTS

Intrauterine pathology was successfully resected by hysteroscopy in 23 (100.0%) out of 23 cases. Following hysteroscopy, 18 (78.3%) women reported amenorrhea, one (4.3%) regular spotting, three (13.0%) irregular spotting and one (4.3%) patient resumed normal menstrual cycle. We conclude that 19 (82.6%) patients were postoperatively asymptomatic. All procedures were uncomplicated and 4 (17.4%) were carried out without general anesthesia as office procedures.

CONCLUSION

Endometrial polyps and submucous leiomyomas can develop in LNG-IUS users, and this can cause irregular uterine bleeding. Hysteroscopic resection of these pathologies is a feasible method in the clinical management of symptoms.

摘要

介绍

本研究旨在评估在使用左炔诺孕酮宫内节育系统(LNG-IUS)的妇女中,宫腔镜检查和手术治疗子宫内膜息肉和黏膜下肌瘤相关症状的可行性和有效性。

材料和方法

招募了 23 名 LNG-IUS 使用者,这些患者有子宫内膜息肉和/或黏膜下肌瘤和不规则子宫出血,进行宫腔镜检查和手术。通过宫腔镜切除 LNG-IUS 来研究和治疗宫内病变,并在三到六个月后评估手术对症状的影响。

结果

23 例(100.0%)中的 23 例成功地通过宫腔镜切除了宫内病变。宫腔镜检查后,18 例(78.3%)患者闭经,1 例(4.3%)患者出现规律点状出血,3 例(13.0%)患者出现不规则点状出血,1 例(4.3%)患者恢复正常月经周期。我们得出结论,19 例(82.6%)患者术后无症状。所有手术均无并发症,其中 4 例(17.4%)作为门诊手术在没有全身麻醉的情况下进行。

结论

LNG-IUS 使用者可出现子宫内膜息肉和黏膜下肌瘤,并可引起不规则子宫出血。宫腔镜切除这些病变是治疗症状的一种可行方法。

相似文献

1
Hysteroscopic management of endometrial polyps and submucous leiomyomas in women using a levonorgestrel-releasing intrauterine system.左炔诺孕酮宫内缓释系统治疗子宫内膜息肉和黏膜下子宫肌瘤的宫腔镜处理。
Minim Invasive Ther Allied Technol. 2022 Apr;31(4):615-619. doi: 10.1080/13645706.2020.1870499. Epub 2021 Jan 11.
2
Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.左炔诺孕酮宫内节育系统用于辅助三苯氧胺治疗的乳腺癌妇女的子宫内膜保护。
Cochrane Database Syst Rev. 2020 Dec 21;12(12):CD007245. doi: 10.1002/14651858.CD007245.pub4.
3
Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.左炔诺孕酮宫内节育系统用于辅助他莫昔芬治疗的乳腺癌女性的子宫内膜保护
Cochrane Database Syst Rev. 2015 Dec 9;2015(12):CD007245. doi: 10.1002/14651858.CD007245.pub3.
4
Hysteroscopic management of displaced levonorgestrel-releasing intrauterine system.移位左炔诺孕酮宫内节育系统的宫腔镜处理
J Obstet Gynaecol Res. 2013 May;39(5):1014-8. doi: 10.1111/jog.12007. Epub 2013 Mar 17.
5
Prevention of Benign Endometrial Polyp Recurrence Using a Levonorgestrel-releasing Intrauterine System in Premenopausal Patients: A Retrospective Cohort Study.绝经前患者应用左炔诺孕酮宫内缓释系统预防良性子宫内膜息肉复发的回顾性队列研究。
J Minim Invasive Gynecol. 2020 Sep-Oct;27(6):1281-1286. doi: 10.1016/j.jmig.2019.11.023. Epub 2020 May 21.
6
Treatment of Women With an Endometrial Polyp and Heavy Menstrual Bleeding: A Levonorgestrel-Releasing Intrauterine Device or Hysteroscopic Polypectomy?子宫内膜息肉伴月经过多的女性的治疗:左炔诺孕酮宫内节育器还是宫腔镜下息肉切除术?
J Minim Invasive Gynecol. 2015 Nov-Dec;22(7):1153-62. doi: 10.1016/j.jmig.2015.06.016. Epub 2015 Jul 4.
7
Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.左炔诺孕酮宫内节育系统用于辅助他莫昔芬治疗的乳腺癌女性的子宫内膜保护
Cochrane Database Syst Rev. 2009 Oct 7(4):CD007245. doi: 10.1002/14651858.CD007245.pub2.
8
Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.用于治疗月经过多的孕激素或释放孕激素的宫内节育系统。
Cochrane Database Syst Rev. 2005 Oct 19(4):CD002126. doi: 10.1002/14651858.CD002126.pub2.
9
Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.使用左炔诺孕酮宫内节育系统治疗特发性月经过多或子宫肌瘤所致月经过多患者的子宫体积和月经模式
Contraception. 2007 Mar;75(3):193-8. doi: 10.1016/j.contraception.2006.11.004. Epub 2007 Jan 16.
10
Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.用于治疗月经过多的孕激素或释放孕激素的宫内节育系统。
Cochrane Database Syst Rev. 2015 Apr 30(4):CD002126. doi: 10.1002/14651858.CD002126.pub3.